Clover Biopharmaceuticals

2 followers


Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases.

Industries

Headquarters

Chengdu, China

Employees

501-1,000

Links


Org chart

Peng Liang
Co-Founder, President & Chairman
Collapse
Joshua Liang
Chief Executive Officer & Board Director
Yang Li
Svp,pd&mst
Mike Berry
Chief Technical Operations Officer
Liongho Chua
President of Greater China
Nicolas Burdin
EVP & Global Head of Research
Tracy Wang
SVP, Head of Regulatory Affairs, China
Wei Tan
SVP & Head of China Research & External Collaboration
François Verdier
Head of Global Regulatory Affairs
Zheng Ping
Director, Operations & Board Director
Vincent Mwangi
Vice President Clinical Operations/medical Affairs- Vaccines
Terence Kwan
Senior Director, Project Development
Zhang Xiaowei
Head Of Talent Acquisition
Oscar Shen
Head Of Human Resources
Wei Shengxi
Director - Global HR Share Service
Jeff Farrow
Independent Non-executive Board Member

Board & advisors

Jianwei Zhu
Founding Advisor & Board Director
Jinyou Zhang
Advisor, Biomanufacturing
Karl Zhou
Advisor, Clinical Development
Shun Luo
Advisor, Process Development
Xiaodong Wang
Founding Advisor & Board Director
Thomas Leggett
Independent Non-executive Director
Xiaobin Wu
Independent Non-executive Director
Xiang Liao
Independent Non-executive Director
Jeffrey Farrow
Independent Non-executive Director
Ting Xiao
Non-executive Director
Dong Lyu
Non-executive Director
Ralf Clemens
Chairman of the Scientific Advisory Board
Anh Wartel
Advisor
Donna Ambrosino
Board Member